Pay in 4 interest-free payments of $6.80 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
A small number of human studies from the 1980s and 1990s reported improvements in sleep architecture and reduced insomnia symptoms, but these trials had very small sample sizes (often under 20 subjects), lacked rigorous controls, and have not been replicated with modern methodology
Bn cng nn chn mt trong nhng a ch bn l c uy tn v h s kinh doanh hng chnh hng, cht lng
Description DSIP Delta Sleep-Inducing Peptide research material for neuropeptide/pathway studies Research Application Focus DSIP is supplied for controlled laboratory investigation of neuropeptide signaling, stress-axis interactions, and central/peripheral pathway crosstalk under defined experimental conditions
Ingredients Serving Size: 1 Capsule Servings Per Container: 60 Body Protective Compound 500mcg -(as BPC-157 Arginate Salt) Salcaprozate Sodium (SNAC) 1.5mg Other Ingredients: cellulose, magnesium stearate, silicone dioxide
Aged mice (12 months, roughly equivalent to middle age in humans) administered MOTS-c for four weeks showed improved physical performance, grip strength, and metabolic markers compared to controls
Nishi, O., Nishi, K., Nishi, Y
US$ 25.84
US$ 21.75
